Stratifying patients with peripheral neuropathic pain based on sensory profiles: algorithm and sample size recommendations
In a recent cluster analysis, it has been shown that patients with peripheral neuropathic pain
can be grouped into 3 sensory phenotypes based on quantitative sensory testing profiles …
can be grouped into 3 sensory phenotypes based on quantitative sensory testing profiles …
Peripheral neuropathic pain: a mechanism-related organizing principle based on sensory profiles
R Baron, C Maier, N Attal, A Binder, D Bouhassira… - Pain, 2017 - journals.lww.com
Patients with neuropathic pain are heterogeneous in etiology, pathophysiology, and clinical
appearance. They exhibit a variety of painrelated sensory symptoms and signs (sensory …
appearance. They exhibit a variety of painrelated sensory symptoms and signs (sensory …
Stratification of patients based on the Neuropathic Pain Symptom Inventory: development and validation of a new algorithm
The personalization of neuropathic pain treatment could be improved by identifying specific
sensory phenotypes (ie, specific combinations of symptoms and signs) predictive of the …
sensory phenotypes (ie, specific combinations of symptoms and signs) predictive of the …
Individualized neuropathic pain therapy based on phenotyping: are we there yet?
J Forstenpointner, J Otto, R Baron - Pain, 2018 - journals.lww.com
Patients with the same neuropathic pain disorder may have completely different sensory
signs and symptoms yet receive the same medicinal treatment. New concepts suggest that …
signs and symptoms yet receive the same medicinal treatment. New concepts suggest that …
Pathophysiological mechanisms of neuropathic pain: comparison of sensory phenotypes in patients and human surrogate pain models
As an indirect approach to relate previously identified sensory phenotypes of patients
suffering from peripheral neuropathic pain to underlying mechanisms, we used a published …
suffering from peripheral neuropathic pain to underlying mechanisms, we used a published …
A cross-sectional cohort survey in 2100 patients with painful diabetic neuropathy and postherpetic neuralgia: differences in demographic data and sensory symptoms
R Baron, TR Tölle, U Gockel, M Brosz, R Freynhagen - Pain, 2009 - Elsevier
Patients with neuropathic pain syndromes are heterogeneous. They present with a variety of
sensory symptoms and pain qualities. The knowledge of these data and etiology-specific …
sensory symptoms and pain qualities. The knowledge of these data and etiology-specific …
Personalized treatment of neuropathic pain: Where are we now?
D Bouhassira, N Attal - European Journal of Pain, 2023 - Wiley Online Library
Background The treatment of neuropathic pain remains a major unmet need that the
development of personalized and refined treatment strategies may contribute to address …
development of personalized and refined treatment strategies may contribute to address …
Identification of cut-points for mild, moderate and severe pain due to diabetic peripheral neuropathy
DC Zelman, E Dukes, N Brandenburg, A Bostrom… - Pain, 2005 - Elsevier
This study identified discrete categories of pain severity in a sample of patients with painful
diabetic peripheral neuropathy (DPN), through derivation of cut-points on a 0–10 scale of …
diabetic peripheral neuropathy (DPN), through derivation of cut-points on a 0–10 scale of …
[HTML][HTML] Neuropathic pain phenotyping as a predictor of treatment response in painful diabetic neuropathy: data from the randomized, double-blind, COMBO-DN study
Sensory profiles are heterogeneous in neuropathic pain disorders, and subgroups of
patients respond differently to treatment. To further explore this, patients in the COMBO-DN …
patients respond differently to treatment. To further explore this, patients in the COMBO-DN …
A novel tool for the assessment of pain: validation in low back pain
J Scholz, RJ Mannion, DE Hord, RS Griffin… - PLoS …, 2009 - journals.plos.org
Background Adequate pain assessment is critical for evaluating the efficacy of analgesic
treatment in clinical practice and during the development of new therapies. Yet the currently …
treatment in clinical practice and during the development of new therapies. Yet the currently …